A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial / Sierra, J; Szer, J; Kassis, J; Herrmann, R; Lazzarino, M; Thomas, X; Noga, Sj; Baker, N; Dansey, R; Bosi, Alberto. - In: BMC CANCER. - ISSN 1471-2407. - STAMPA. - 8:(2008), pp. 195-199.

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.

BOSI, ALBERTO
2008
2008
BMC CANCER
8
195
199
Sierra, J; Szer, J; Kassis, J; Herrmann, R; Lazzarino, M; Thomas, X; Noga, Sj; Baker, N; Dansey, R; Bosi, Alberto
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
art%3A10.1186%2F1471-2407-8-195.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 352 kB
Formato Adobe PDF
352 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/338592
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 46
social impact